Ifars Pharmaceutical Laboratories

Ifars Pharmaceutical Laboratories, established in 1974, is a prominent pharmaceutical manufacturing entity based in Indonesia. The company specializes in the development and production of high-quality, affordable medicinal products, maintaining a rigorous focus on patient health outcomes. By integrating advanced pharmacovigilance protocols, the organization ensures the safety and efficacy of its diverse therapeutic offerings, positioning itself as a trusted provider within the competitive healthcare sector.

Operating with a workforce of 500-1,000 employees at its primary facility in Kabupaten Karanganyar, the company maintains a streamlined operational footprint. Their extensive product portfolio includes specialized medications such as DEVOSIX Drops, FINAZIDE Tablets, VALENIX Gel, and BAXIDERM Salep, which address various clinical needs. Meet Ifars Pharmaceutical Laboratories's team to gain insights into the leadership and technical expertise driving these manufacturing processes. The company leverages its single-site infrastructure to maintain strict quality control standards across all production lines.

Ifars Pharmaceutical Laboratories continues to expand its influence in the Indonesian pharmaceutical market by prioritizing accessibility and therapeutic reliability. The firm remains dedicated to meeting the evolving health requirements of its client base through continuous innovation and adherence to international manufacturing standards. By focusing on core competencies in pharmaceutical synthesis and distribution, the company sustains its reputation as a reliable partner in the regional healthcare ecosystem, consistently delivering essential medical solutions to the public.